NeOnc Technologies Holdings Stock (NASDAQ:NTHI)

Ownership Financials Chart

Previous Close

$4.69

52W Range

$3.00 - $12.99

50D Avg

$4.13

200D Avg

$6.77

Market Cap

$122.14M

Avg Vol (3M)

$148.94K

Beta

0.50

Div Yield

-

NTHI Company Profile

NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. It develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company was founded in 2008 and is headquartered in Calabasas, CA.

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

5

IPO Date

Mar 26, 2025

Website

NTHI Performance

NTHI Financial Summary

	Dec 24	Dec 23	Dec 22
Revenue	$83.00K	$70.46K	$20.00K
Operating Income	$-7.14M	$-12.20M	$-2.84M
Net Income	$-11.90M	$-14.92M	$-3.05M
EBITDA	$-9.10M	$-12.20M	$-2.85M
Basic EPS	$-0.63	$-0.80	$-0.16
Diluted EPS	$-0.63	$-0.80	$-0.16

Fiscal year ends in Dec 24 | Currency in USD